Table of contents
Volume 90, Issue 6
Published online 16 March 2004 (1111-1296)
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor |
Book Review
Minireviews
Expression profiling of small cellular samples in cancer: less is more FREE
J G Glanzer and J H Eberwine
Br J Cancer 90: 1111-1114; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601668
Establishing a tumour bank: banking, informatics and ethics FREE
S J Qualman, M France, W E Grizzle, V A LiVolsi, C A Moskaluk, N C Ramirez and M K Washington
Br J Cancer 90: 1115-1119; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601678
Molecular profiling of breast cancer: clinical implications FREE
S Cleator and A Ashworth
Br J Cancer 90: 1120-1124; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601667
Clinical
Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma FREE
I Sekine, H Nokihara, A Horiike, N Yamamoto, H Kunitoh, Y Ohe, T Tamura, T Kodama and N Saijo
Br J Cancer 90: 1125-1128; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601700
The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer FREE
M D Barber, D C McMillan, A M Wallace, J A Ross, T Preston and K C H Fearon
Br J Cancer 90: 1129-1132; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601712
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies FREE
J J Body, I J Diel, M Lichinitzer, A Lazarev, M Pecherstorfer, R Bell, D Tripathy and B Bergstrom
Br J Cancer 90: 1133-1137; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601663
Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment FREE
A M Ugnat, L Xie, J Morriss, R Semenciw and Y Mao
Br J Cancer 90: 1138-1143; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601662
Patient's needs and preferences in routine follow-up after treatment for breast cancer FREE
G H de Bock, J Bonnema, R E Zwaan, C J H van de Velde, J Kievit and A M Stiggelbout
Br J Cancer 90: 1144-1150; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601655
Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma FREE
J Spicer, P Smith, K Maclennan, P Hoskin, B Hancock, D Linch and R Pettengell
Br J Cancer 90: 1151-1155; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601675
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma FREE
P F Geertsen, M E Gore, S Negrier, J M Tourani and H von der Maase
Br J Cancer 90: 1156-1162; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601709
A population-based study of pain and quality of life during the year before death in men with prostate cancer FREE
G Sandblom, P Carlsson, K Sennfält and E Varenhorst
Br J Cancer 90: 1163-1168; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601654
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours FREE
I A McNeish, E J Kanfer, R Haynes, C Giles, S J Harland, D Driver, G J S Rustin, E S Newlands and M J Seckl
Br J Cancer 90: 1169-1175; advance online publication, March 9, 2004; doi:10.1038/sj.bjc.6601664
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning FREE
M R van Dijk, E W Steyerberg, S P Stenning, E Dusseldorp and J D F Habbema
Br J Cancer 90: 1176-1183; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601665
Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer FREE
N Yoshimura, S Kudoh, T Mukohara, S Yamauchi, M Yamada, T Kawaguchi, Y Nakaoka, K Hirata and J Yoshikawa
Br J Cancer 90: 1184-1189; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601672
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials FREE
E Van Cutsem, P M Hoff, P Harper, R M Bukowski, D Cunningham, P Dufour, U Graeven, J Lokich, S Madajewicz, J A Maroun, J L Marshall, E P Mitchell, G Perez-Manga, P Rougier, W Schmiegel, J Schoelmerich, A Sobrero and R L Schilsky
Br J Cancer 90: 1190-1197; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601676
Molecular and Cellular Pathology
Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers FREE
K T Lee, Y W Lee, J K Lee, S H Choi, J C Rhee, S S Paik and G Kong
Br J Cancer 90: 1198-1203; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601684
Allelic loss at 19q12 and Xq11–12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential FREE
K Nakayama, Y Takebayashi, K Hata, R Fujiwaki, K Iida, M Fukumoto and K Miyazaki
Br J Cancer 90: 1204-1210; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601681
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR FREE
S Gal, C Fidler, Y M D Lo, M Taylor, C Han, J Moore, A L Harris and J S Wainscoat
Br J Cancer 90: 1211-1215; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601609
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905) FREE
J P Dales, S Garcia, S Carpentier, L Andrac, O Ramuz, M N Lavaut, C Allasia, P Bonnier and C Taranger-Charpin
Br J Cancer 90: 1216-1221; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601452
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours FREE
S Lantuejoul, J C Soria, D Moro-Sibilot, L Morat, S Veyrenc, P Lorimier, P Y Brichon, L Sabatier, C Brambilla and E Brambilla
Br J Cancer 90: 1222-1229; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601643
Genetics and Genomics
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases FREE
M Karoui, C Tresallet, C Julie, U Zimmermann, F Staroz, A Brams, C Muti, C Boulard, A-M Robreau, H Puy, R Malafosse, C Penna, F-R Pruvot, J P Thiery, C Boileau, P Rougier, B Nordlinger, F Radvanyi, B Franc and H Hofmann-Radvanyi
Br J Cancer 90: 1230-1234; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601687
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene FREE
C C Wykoff, C Sotiriou, M E Cockman, P J Ratcliffe, P Maxwell, E Liu and A L Harris
Br J Cancer 90: 1235-1243; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601657
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families FREE
K Claes, B Poppe, I Coene, A De Paepe and L Messiaen
Br J Cancer 90: 1244-1251; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601656
Experimental Therapeutics
Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool FREE
H Hashida, M Miyamoto, Y Cho, Y Hida, K Kato, T Kurokawa, S Okushiba, S Kondo, H Dosaka-Akita and H Katoh
Br J Cancer 90: 1252-1258; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601680
In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats FREE
S Zeamari, G Rumping, B Floot, S Lyons and F A Stewart
Br J Cancer 90: 1259-1264; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601637
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells FREE
A Miyoshi, Y Kitajima, K Sumi, K Sato, A Hagiwara, Y Koga and K Miyazaki
Br J Cancer 90: 1265-1273; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601685
Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage FREE
P M Sanders and M J Tisdale
Br J Cancer 90: 1274-1278; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601669
TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model FREE
A M Waterston, F Salway, E Andreakos, D M Butler, M Feldmann and R C Coombes
Br J Cancer 90: 1279-1284; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601670
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin FREE
H-J Tang, D Qian, V K Sondak, S Stachura and J Lin
Br J Cancer 90: 1285-1292; advance online publication, February 24, 2004; doi:10.1038/sj.bjc.6601653
Letters to the Editor
PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide? FREE
E Maioli and V Fortino
Br J Cancer 90: 1293-1294; doi:10.1038/sj.bjc.6601689
Reply: PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide? FREE
R P Hoey, C Sanderson, J Iddon, G Brady, N J Bundred and N G Anderson
Br J Cancer 90: 1295; advance online publication, March 2, 2004; doi:10.1038/sj.bjc.6601690
Book Review
Oncologic Therapies FREE
S J Strauss
Br J Cancer 90: 1296; doi:10.1038/sj.bjc.6601671
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
